Growth Metrics

Opus Genetics (IRD) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -10.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 26.38%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -46.86%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 34.98%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Opus Genetics 357.99 Mn 298.03 Mn - -124.51%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -124.51%
Dec 31, 2025 -35.48%
Sep 30, 2025 -56.76%
Jun 30, 2025 -14.62%
Mar 31, 2025 -7.50%
Dec 31, 2024 -77.22%
Sep 30, 2024 -21.17%
Jun 30, 2024 -2.86%
Mar 31, 2024 43.31%
Dec 31, 2023 36.45%
Sep 30, 2023 86.20%
Jun 30, 2023 -45.70%
Mar 31, 2023 -23.32%
Dec 31, 2022 284.41%
Sep 30, 2022 -32.24%
Jun 30, 2022 -25.98%
Mar 31, 2022 -41.19%
Dec 31, 2021 -26.53%
Sep 30, 2021 7.47%
Jun 30, 2021 -22.96%
Mar 31, 2021 -165.92%
Dec 31, 2020 -73.25%
Sep 30, 2020 -6.33%
Jun 30, 2020 -54.58%
Mar 31, 2020 47.72%
Dec 31, 2019 46.39%
Sep 30, 2019 11.92%
Jun 30, 2019 -11.75%
Mar 31, 2019 17.34%
Dec 31, 2018 -3.00%
Sep 30, 2018 -9.86%
Jun 30, 2018 -5.87%
Mar 31, 2018 21.39%
Dec 31, 2017 -17.58%
Sep 30, 2017 18.33%
Jun 30, 2017 69.50%
Mar 31, 2017 -13.96%
Dec 31, 2016 42.19%
Sep 30, 2016 -10.22%
Jun 30, 2016 17.18%
Mar 31, 2016 -39.45%
Dec 31, 2015 -272.00%
Sep 30, 2015 -10.44%
Jun 30, 2015 -45.85%
Mar 31, 2015 -25.91%
Dec 31, 2014 -97.28%
Sep 30, 2014 -9.05%
Jun 30, 2014 26.69%
Mar 31, 2014 -48.75%
Dec 31, 2013 -1.38%
Sep 30, 2013 -127.54%
Jun 30, 2013 4.75%